- $1.45bn
- $2.85bn
- $3.40bn
- 81
- 78
- 57
- 84
Annual income statement for Cimpress, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,576 | 2,888 | 3,080 | 3,292 | 3,403 |
| Cost of Revenue | |||||
| Gross Profit | 1,276 | 1,395 | 1,439 | 1,597 | 1,622 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,501 | 2,840 | 3,016 | 3,045 | 3,177 |
| Operating Profit | 75.2 | 47.3 | 64.1 | 247 | 226 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -63.6 | 9.33 | -30.2 | 128 | 97 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -82.5 | -50.6 | -186 | 178 | 12.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -85.2 | -54.3 | -186 | 174 | 15 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -85.2 | -54.3 | -186 | 174 | 15 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1 | -1.96 | -5.86 | 6.49 | 0.938 |